A non-adherent to collagen or gelatin matrix culture sequence forms proliferative hepatocyte spheroids that retain liver function for longer studies.
A tuned expansion medium with Wnt agonists, RTK ligands, TGF-beta inhibitors, and cAMP activators extends epithelial stem cell culture while preserving differentiation.
A fetal liver/yolk sac organoid coculture and bioreactor approach scales CD71+ cell production for immunosuppressive cell therapy.
Specific HNF1, HNF6, and FOXA factor combinations reprogram non-hepatic cells into liver progenitors with long-term growth and dual differentiation.
A 3D cell cartridge and plasma separator restore hepatocyte-like detoxification, reducing metabolic burden during acute liver failure.
Localized cell-aggregate biomaterials preserve immunomodulatory function over time, reducing phenotype drift and systemic immunosuppressant use.
A staged expansion and differentiation medium boosts progenitor cell efficiency and yields liver organoids closer to in vivo hepatocytes.
Non-adherent culture plus GelMa embedding forms 3D hepatic cells that proliferate and differentiate without DMSO-driven CYP3A4 induction.
Fibroblast-like feeder cells derived from pluripotent stem cell intestinal structures enable 2D maintenance and expansion of intestinal epithelial cells.
A feeder-free, animal-free multi-stage culture medium shortens hepatocyte induction while increasing cell yield, purity, and stability.
A cleavable HAMA-GelMA bioink enables high-fidelity DLP printing, then enzymatic softening to support cell growth and differentiation.
Hormone-conditioned liver organoids improve gluconeogenesis and urea production, enabling more reliable drug evaluation without primary hepatocyte limits.
Floating mixed stem, endothelial, and organ cells in microfibers enables scalable organoid aggregate production with even cell distribution.
Specific mRNA combinations guide stem cells into functional hepatocytes while avoiding costly growth factors, complex media, and genomic integration.
A 3D liver microtissue with hepatocytes, Kupffer cells, and endothelial cells models NASH and fibrosis for high-throughput screening.